Hisamitsu Pharmaceutical Co (TSE:4530) FFO


TSE:4530 Hisamitsu Pharmaceutical Co Inc TSE:4530
68 GF Score
Price 円6,040.00
GF Value 円4,918.72
Valuation Modestly Overvalued
View Full Analysis

What is Hisamitsu Pharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

TSE:4530
68GF Score
Hisamitsu Pharmaceutical Co Inc TSE:4530
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hisamitsu Pharmaceutical Co (TSE:4530) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of 円6,040.00 is trading 22.8% above its estimated GF Value™ of 円4,918.72. GuruFocus considers Hisamitsu Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4530:

  • FFO:
  • GF Value™: 円4,918.72 vs. price of 円6,040.00 (22.8% above fair value)
  • GF Score™: 68/100

No single metric tells the full story. See the TSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
68GF Score

Get the complete analysis for TSE:4530

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円6,040.00
Price
円4,918.72
GF Value